BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32286386)

  • 1. Effects of orthotopic implantation of rat prostate tumour cells upon components of the N-acylethanolamine and monoacylglycerol signalling systems: an mRNA study.
    Alhouayek M; Stafberg L; Karlsson J; Bergström SH; Fowler CJ
    Sci Rep; 2020 Apr; 10(1):6314. PubMed ID: 32286386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
    Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells.
    Wang J; Zhao LY; Uyama T; Tsuboi K; Wu XX; Kakehi Y; Ueda N
    J Biochem; 2008 Nov; 144(5):685-90. PubMed ID: 18806270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).
    Ueda N; Tsuboi K; Uyama T
    Prog Lipid Res; 2010 Oct; 49(4):299-315. PubMed ID: 20152858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon γ treatment increases endocannabinoid and related N-acylethanolamine levels in T84 human colon carcinoma cells.
    Alhouayek M; Rankin L; Gouveia-Figueira S; Fowler CJ
    Br J Pharmacol; 2019 May; 176(10):1470-1480. PubMed ID: 29313885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells.
    Karlsson J; Gouveia-Figueira S; Alhouayek M; Fowler CJ
    PLoS One; 2017; 12(9):e0185011. PubMed ID: 28910408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
    Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
    Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2.
    Kaczocha M; Glaser ST; Chae J; Brown DA; Deutsch DG
    J Biol Chem; 2010 Jan; 285(4):2796-806. PubMed ID: 19926788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period.
    Lee TT; Hill MN; Hillard CJ; Gorzalka BB
    Synapse; 2013 Jan; 67(1):4-10. PubMed ID: 22987804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
    Pertwee RG
    Proc Nutr Soc; 2014 Feb; 73(1):96-105. PubMed ID: 24135210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines.
    Brown I; Wahle KW; Cascio MG; Smoum-Jaouni R; Mechoulam R; Pertwee RG; Heys SD
    Prostaglandins Leukot Essent Fatty Acids; 2011 Dec; 85(6):305-10. PubMed ID: 21995886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats.
    Charrua A; Matos R; Oliveira R; Marczylo T; Nagy I; Cruz F
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):263-272. PubMed ID: 31522241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccenic acid suppresses intestinal inflammation by increasing anandamide and related N-acylethanolamines in the JCR:LA-cp rat.
    Jacome-Sosa M; Vacca C; Mangat R; Diane A; Nelson RC; Reaney MJ; Shen J; Curtis JM; Vine DF; Field CJ; Igarashi M; Piomelli D; Banni S; Proctor SD
    J Lipid Res; 2016 Apr; 57(4):638-49. PubMed ID: 26891736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase.
    Long JZ; LaCava M; Jin X; Cravatt BF
    J Lipid Res; 2011 Feb; 52(2):337-44. PubMed ID: 21097653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipidomic analysis of N-acylphosphatidylethanolamine molecular species in Arabidopsis suggests feedback regulation by N-acylethanolamines.
    Kilaru A; Tamura P; Isaac G; Welti R; Venables BJ; Seier E; Chapman KD
    Planta; 2012 Sep; 236(3):809-24. PubMed ID: 22673881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
    Alhouayek M; Bottemanne P; Subramanian KV; Lambert DM; Makriyannis A; Cani PD; Muccioli GG
    FASEB J; 2015 Feb; 29(2):650-61. PubMed ID: 25384424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of anandamide (AEA) metabolic enzymes in rat placental bed.
    Fonseca BM; Battista N; Correia-da-Silva G; Rapino C; Maccarrone M; Teixeira NA
    Reprod Toxicol; 2014 Nov; 49():74-7. PubMed ID: 25088244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines.
    Mulder AM; Cravatt BF
    Biochemistry; 2006 Sep; 45(38):11267-77. PubMed ID: 16981687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity.
    Hansen HS; Moesgaard B; Hansen HH; Schousboe A; Petersen G
    Lipids; 1999; 34 Suppl():S327-30. PubMed ID: 10419193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.
    Bottemanne P; Guillemot-Legris O; Paquot A; Masquelier J; Malamas M; Makriyannis A; Alhouayek M; Muccioli GG
    Neurotherapeutics; 2021 Jul; 18(3):1815-1833. PubMed ID: 34235639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.